TruSight™ Oncology Comprehensive, an in vitro diagnostic (IVD) test, enables precision medicine by offering healthcare providers the genomic insights into what is driving their patient’s cancer. Through comprehensive genomic profiling (CGP), patients can be genomically matched to therapy regimens, which have been shown to improve outcomes. Learn more about how this IVD test can improve access to CGP and inform decision making for cancer patients. https://www.illumina.com/destination/TSO-Comprehensive-IVD.html For In Vitro Diagnostic Use. Not available in all countries or regions. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM LinkedIn: https://www.linkedin.com/company/illumina X: https://x.com/illumina Instagram: https://www.instagram.com/illuminainc/ Facebook: https://www.facebook.com/illuminainc TikTok: https://www.tiktok.com/@illuminainc